NovaBay Pharmaceuticals NBY
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 6.40 | 94.22 | 3.21 | -0.25 | -1,256 | -1 |
| 2025Q2 | 2.90 | 96.28 | 1.27 | -0.41 | -1,891 | -2 |
| 2025Q1 | 2.93 | 98.80 | 1.42 | -3,290 | 8 | |
| 2024Q4 | 3.01 | 20.50 | 5.43 | -228 | -1 | |
| 2024Q3 | 3.45 | 36.60 | -2.39 | -642 | -1 | |
| 2024Q2 | 11.05 | 45.81 | 24.38 | -1,198 | -2 | |
| 2024Q1 | 18.32 | 61.59 | -29.95 | -2,436 | -3 | |
| 2023Q4 | 35.70 | 86.34 | -59.56 | -4,502 | -4 | |
| 2023Q3 | 78.75 | 73.57 | -2.16 | -1,809 | -2 | |
| 2023Q2 | 131.64 | 71.77 | -47.67 | -1,744 | -2 | |
| 2023Q1 | 297.50 | 99.71 | -29.75 | -1,734 | -2 | |
| 2022Q4 | 341.25 | 114.87 | -167.31 | -9,426 | -8 | |
| 2022Q3 | 673.75 | 336.03 | -132.31 | -457 | 0 | |
| 2022Q2 | 1531.25 | 99.86 | -51.10 | -2,152 | -2 | |
| 2022Q1 | 1814.84 | 2145.95 | -2.80 | -2,382 | 0 | |
| 2021Q4 | 2306.68 | 2021.52 | -24.87 | -3,194 | 0 | |
| 2021Q3 | 3935.31 | -61.25 | -2,289 | -2 | ||
| 2021Q2 | 4112.33 | -49.00 | -1,859 | -2 | ||
| 2021Q1 | 5573.75 | 100.13 | -49.00 | -1,520 | -2 | |
| 2020Q4 | 4269.13 | 100.46 | -36.75 | -1,758 | -2 |